References
- KievitFMWangFYFangCDoxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitroJ Control Release20111521768321277920
- MaBChaiSLiNReversal of P-glycoprotein-mediated multi-drug resistance by a synthetic α-aminoxy peptidomimeticInt J Pharm20124241–2333922226881
- XuHBLiLLiuGQReversal of multidrug resistance by guggulsterone in drug-resistant MCF-7 cell linesChemotherapy2011571627021282948
- WangFZhangDZhangQSynergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel-polymer micelles to overcome multi-drug resistanceBiomaterials201132359444945621903258
- ElamanchiliPMcEachernCBurtHReversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein functionJ Pharm Sci200998394595818623213
- LiangZWuHXiaJInvolvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Biochem Pharmacol201079681782419883630
- PatilYSadhukhaTMaLPanyamJNanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistanceJ Control Release20091361212919331851
- GottesmanMMPastanIBiochemistry of multidrug resistance mediated by the multidrug transporterAnnu Rev Biochem19936213854278102521
- GeorgesESharomFJLingVMultidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapyAdv Pharmacol1990211852202265126
- QiuLYYanLZhangLJinYMZhaoQHFolate-modified poly (2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin deliveryInt J Pharm2013456231532424016742
- BatrakovaEVLiSElmquistWFMillerDWAlakhovVYKabanovAVMechanism of sensitization of MDR cancer cells by Pluronic block copolymers: selective energy depletionBr J Cancer200185121987199711747344
- ValleJWArmstrongANewmanCA phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junctionInvest New Drugs20112951029103720179989
- WangAZLangerRFarokhzadOCNanoparticle delivery of cancer drugsAnnu Rev Med201163118519821888516
- BatrakovaEVKellyDLLiSAlteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85Mol Pharm20063211312316579640
- KabanovAVBatrakovaEVAlakhovVYPluronic block copolymers for overcoming drug resistance in cancerAdv Drug Deliv Rev200254575977912204601
- BansalTAkhtarNJaggiMKharRKTalegaonkarSNovel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulationDrug Discov Today20091421–221067107419647803
- JiQQiuLMechanism study of PEGylated polyester and β-cyclodextrin integrated micelles on drug resistance reversal in MRP1-overexpressed HL60/ADR cellsColloids Surf B Biointerfaces201614420321327088190
- GaoMXuYQiuLEnhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomesInt J Nanomedicine2015106615663226543365
- ZhangYLiuXZuoTLiuYZhangJHTetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoproteinMed Oncol201229253453821562851
- DuanJMansourHMZhangYReversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly (butyl cyanoacrylate) nanoparticlesInt J Pharm20124261–219320122274587
- SchneiderEHortonJKYangCHNakagawaMCowanKHMultidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistanceCancer Res19945411521587903202
- BenderraZTrussardiAMorjaniHVillaAMDogliaSMManfaitMRegulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated proteinEur J Cancer200036342843410708946
- QiuLYWangRJZhengCJinYJin leQBeta-cyclodextrin-centered star-shaped amphiphilic polymers for doxorubicin deliveryNanomedicine(Lond)20105219320820148632
- QiuLZhangLZhengCWangRImproving physicochemical properties and doxorubicin cytotoxicity of novel polymeric micelles by poly (ε-caprolactone) segmentsJ Pharm Sci201110062430244221491452
- YuJJLeeHAKimJHBio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicinJ Drug Target200715427928417487696
- DongYFengSSMethoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugsBiomaterials200425142843284914962562
- IchiTWatanabeJOoyaTYuiNControllable erosion time and profile in poly(ethylene glycol) hydrogels by supramolecular structure of hydrolyzable polyrotaxaneBiomacromolecules20012120421011749174
- TangGPGuoHYAlexisFLow molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous systemJ Gene Med20068673674416550629
- ZhangLLuJFJinYMQiuLYFolate-conjugated beta-cyclodextrin-based polymeric micelles withenhanced doxorubicin antitumor efficacyColloid Surface B2014122260269
- XiaQWangZYLiHQReversion of P-glycoprotein-mediated multidrug resistance in human leukemic cell line by diallyl trisulfideEvid Based Complement Alternat Med2012201271980522919419
- LiuRZhangYChenYA novel calmodulin antagonistO-(4-ethoxyl-butyl)-berbamine overcomes multidrug resistance in drug-resistant MCF-7/ADR breast carcinoma cellsJ Pharm Sci20109973266327520112430
- ShiRLiWZhangXA novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cellsEur J Pharmacol20116691–3384421871878
- KitchensKMKolhatkarRBSwaanPWGhandehariHEndocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cellsMol Pharm20085236436918173246
- PerryJWWobusCEEndocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterolJ Virol201084126163617620375172
- KoivusaloMWelchCHayashiHAmiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signalingJ Cell Biol2010188454756320156964
- MoRJinXLiNThe mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micellesBiomaterials201132204609462021440934
- XuDLuQHuXDown-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiolCancer Lett2006243227428016406853
- KimmelCBBallardWWKimmelSRUllmannBSchillingTFStages of embryonic development of the zebrafishDev Dyn199520332533108589427
- WangYYuLHanLShaXFangXDifunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell linesInt J Pharm20073371–2637317289311
- DuWFanYZhengNTransferrin receptor specific nanocarriers conjugated with functional 7 peptide for oral drug deliveryBiomaterials201334379480623103156
- SharmaAKZhangLLiSPrevention of MDR development in leukemia cells by micelle-forming polymeric surfactantJ Control Release2008131322022718722489
- BatrakovaEVLiSVinogradovSVAlakhovVYMillerDWKabanovAVMechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidizationJ Pharmacol Exp Ther2001299248349311602658
- KabanovAVPolymer genomics: an insight into pharmacology and toxicology of nanomedicinesAdv Drug Deliv Rev200658151597162117126450
- WesołowskaOInteraction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1Acta Biochim Pol201158443344822187677
- BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev2012642436
- MillerDWBatrakovaEVWaltnerTOAlakhovVYuKabanovAVInteractions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorptionBioconjug Chem1997856496579327127
- ConnerSDSchmidSLRegulated portals of entry into the cellNature20034226927374412621426
- GamboaJMLeongKWIn vitro and in vivo models for the study of oral delivery of nanoparticlesAdv Drug Deliv Rev201365680081023415952
- PerumalOPInapagollaRKannanSKannanRMThe effect of surface functionality on cellular trafficking of dendrimersBiomaterials20082924–253469347618501424
- YinLTangHKimKHLight-responsive helical polypeptides capable of reducing toxicity and unpacking DNA: toward nonviral gene deliveryAngew Chem Int Ed Engl201352359182918623832670
- ChiuYLHoYCChenYMThe characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosanJ Control Release2010146115215920580915
- DoigeCASharomFJTransport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cellsBiochim Biophys Acta1992110921611711355667
- KatzirHYeheskely-HayonDRegevREytanGDRole of the plasma membrane leaflets in drug uptake and multidrug resistanceFEBS J201027751234124420121943
- AlakhovaDYRapoportNYBatrakovaEVDifferential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancersJ Control Release201014218910019815037
- AllerSGYuJWardAStructure of P-glycoprotein reveals a molecular basis for poly-specific drug bindingScience200932359221718172219325113
- BorgniaMJEytanGDAssarafYGCompetition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activityJ Biol Chem19962716316331718621716
- GarriguesANugierJOrlowskiSEzanEA high-throughput screening microplate test for the interaction of drugs with P-glycoproteinAnal Biochem2002305110611412018951
- LitmanTSkovsgaardTSteinWDPumping of drugs by P-glycoprotein: a two-step process?J Pharmacol Exp Ther2003307384685314534356
- AmbudkarSVDeySHrycynaCARamachandraMPastanIGottesmanMMBiochemical, cellular, and pharmacological aspects of the multidrug transporterAnnu Rev Pharmacol Toxicol199939136139810331089
- FongWFShenXLGlobischCMethoxylation of 3′,4′-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cellsBioorg Med Chem20081673694370318313307
- LineweaverHBurkDThe determination of enzyme dissociation constantsJ Am Chem Soc1934563658666
- NicholsonCInteraction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatumBiophys J1995685169917157612814
- HealeyFPSlope of the Monod equation as an indicator of advantage in nutrient competitionMicrob Ecol19805428128624232515
- WangRBKuoCLLienLLLienEJStructure-activity relationship: analyses of p-glycoprotein substrates and inhibitorsJ Clin Pharm Ther200328320322812795780
- ZamoraJMPearceHLBeckWTPhysical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cellsMol Pharmacol19883344544623162758
- Sachs-BarrableKThambooALeeSDWasanKMLipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cellsJ Pharm Pharm Sci200710331933117727795
- LooTWBartlettMCClarkeDMSimultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoproteinJ Biol Chem200327841397063971012909621
- YoungSParkerPJUllrichAStabelSDown-regulation of protein kinase C is due to an increased rate of degradationBiochem J198724437757793446191
- MimeaultMBatraSKEmergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsDrug Discov Today2013183–412814022903142
- NicoliSRibattiDCotelliFPrestaMMammalian tumor xenografts induce neovascularization in zebrafish embryosCancer Res20076772927293117409396